ICMR removes ceiling of Rs 4,500 on Coronavirus Tests

▴ ICMR removes ceiling of Rs 4,500 on Coronavirus Tests
Private Labs are free to fix the charges of COVID-19 tests

The Indian Council of Medical Research has removed the price cap of Rs 4,500 for the real-time polymerase chain reaction (RT-PCR) test used to detect COVID-19, asking states and UTs to negotiate with private labs to fix "mutually agreeable" rates for the test.


In a letter to the state chief secretaries on Monday, ICMR Director General (D-G) Dr Balram Bhargava said the COVID-19 diagnostic supplies are stabilising because of the indigenous production of the kits."In this backdrop and keeping in view the evolving prices of testing commodities, the earlier suggested upper ceiling of Rs 4500 vide letter dated March 17, may not be applicable now," he said."Therefore, all state governments/UT administrations are advised to negotiate with private labs and fix up mutually agreeable prices for samples being sent by the government and also for private individuals desirous of testing by these labs," Bhargava said in the letter.

He said at the beginning of the COVID-19 pandemic there was a global crisis of testing kits and reagents as India was heavily reliant on imported products for molecular detection of viruses. As such in mid-march, no rates for RT-PCR tests for coronavirus were available for reference in the country.

"Keeping in view the cost of imported kits and efforts involved in carrying out the test, the ICMR suggested the upper limit of a single test at Rs 4500," the letter said.

There are 428 government and 182 private labs for COVID-19 testing across all states and UTs in the country.

"Now testing supplies are also stabilizing and many of you have started procuring such kits from the local market. Due to varied options of testing materials/kits, including indigenous ones, the prices are becoming competitive and undergoing reduction," Bhargava said.

The ICMR D-G said concerted efforts have been made to ramp up the testing capacity in the country.

"In this intervening period all efforts have been made to facilitate local companies by handholding and promoting them to locally manufacture swabs, viral transport media, and RNA extraction kits. Further, indigenous diagnostic kits are being approved on a fast track basis for RT-PCR testing," he said in the letter.

PTI

Tags : #ICMR #CoronavirusTest #RTPCR #BalramBhargava

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Surviving Against the Odds: Steven Spinale's Journey After an Ingrown Hair Turns DeadlyMarch 29, 2024
10 reasons why media research and Planning are essential in Healthcare marketingMarch 29, 2024
The Surprising Link Between Sleep and Age Perception: What You Need to KnowMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
The Dark Side of Beauty: Kidney Damage from Hair Straightening TreatmentsMarch 29, 2024
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 StudyMarch 29, 2024
Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024